Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 3:50:101197.
doi: 10.1016/j.lanepe.2024.101197. eCollection 2025 Mar.

Dynamic association of antimicrobial resistance in urinary isolates of Escherichia coli and Klebsiella pneumoniae between primary care and hospital settings in the Netherlands (2008-2020): a population-based study

Collaborators, Affiliations

Dynamic association of antimicrobial resistance in urinary isolates of Escherichia coli and Klebsiella pneumoniae between primary care and hospital settings in the Netherlands (2008-2020): a population-based study

Evelyn Pamela Martínez et al. Lancet Reg Health Eur. .

Abstract

Background: It is unclear whether changes in antimicrobial resistance (AMR) in primary care influence AMR in hospital settings. Therefore, we investigated the dynamic association of AMR between primary care and hospitals.

Methods: We studied resistance percentages of Escherichia coli and Klebsiella pneumoniae isolates to co-amoxiclav, ciprofloxacin, fosfomycin, nitrofurantoin and trimethoprim submitted by primary care, hospital outpatient and hospital inpatient settings to the Dutch National AMR surveillance network (ISIS-AR) from 2008 to 2020. For each bacterium-antibiotic combination, we first conducted multivariable logistic regressions to calculate AMR odds ratios (ORs) by month and healthcare setting, adjusted for patient-related factors and a time term. Second, multiple time series analysis was done using vector autoregressive models including the (log) ORs for each bacterium-antibiotic combination. Models were interpreted by impulse response functions and Granger-causality tests.

Findings: The main AMR association was unidirectional from primary care to hospital settings with Granger-causality p-values between <0.0001 and 0.029. Depending on the bacterium-antibiotic combination, a 1% increase of AMR in E. coli and K. pneumoniae in primary care leads to an increase of AMR in hospital settings ranging from 0.10% to 0.40%. For ciprofloxacin resistance in K. pneumoniae, we found significant bidirectional associations between all healthcare settings with Granger-causality p-values between <0.0001 and 0.0075.

Interpretation: For the majority of bacterium-antibiotic combinations, the main AMR association was from primary care to hospital settings. These results underscore the importance of antibiotic stewardship at the community level.

Funding: ISIS-AR is supported by the Ministry of Health, Welfare and Sport of the Netherlands and the first author by the Central University of Ecuador to follow a PhD program in Erasmus MC.

Keywords: Antimicrobial resistance; General practitioners; Granger causality; Health care settings; Multiple time series.

PubMed Disclaimer

Conflict of interest statement

ISIS-AR is supported by the Dutch Ministry of Health, Welfare and Sport. EPM was supported by the Central University of Ecuador to follow a PhD program in Erasmus MC. Other authors are supported by internal funding. Authors have no conflict of interest to declare.

Figures

Fig. 1
Fig. 1
Antimicrobial resistance time trends in E. coli by healthcare settings and antibiotic type in the Netherlands. AMR series for ciprofloxacin, nitrofurantoin and trimethoprim are from 2008 to 2020. AMR series for co-amoxiclav are from 2008 to 2015, while AMR series for fosfomycin are from 2014 to 2020. Adjusted time series (OR of Time) with their 95% CIs (shadows) were calculated by multiple logistic regression analysis adjusted for patient-related factors and calendar time (left y-axis). As reference, the horizontal dotted line shows an OR = 1. Original time series (%) were calculated as the proportion of resistant isolates among the total number of tested isolates for each antibiotic of interest (right y-axis).
Fig. 2
Fig. 2
Antimicrobial resistance time trends in K. pneumoniae by healthcare settings and antibiotic type in the Netherlands. AMR series for ciprofloxacin, nitrofurantoin and trimethoprim are from 2008 to 2020. AMR series for co-amoxiclav are from 2008 to 2015, while AMR series for fosfomycin are from 2014 to 2020. Adjusted time series (OR of Time) with their 95% CIs (shadows) were calculated by multiple logistic regression analysis adjusted for patient related factors and calendar time (left y-axis). As reference, the horizontal dotted line shows an OR = 1. Original time series (%) were calculated as the proportion of resistant isolates among the total number of tested isolates for each antibiotic of interest (right y-axis).
Fig. 3
Fig. 3
Impulse response functions of AMR in E. coli between primary care (PC) hospital outpatient (HO) and hospital inpatient (HI) settings. Solid lines are the estimated impulse responses of AMR after a shock consisting of a 1% relative increase of AMR in each healthcare setting, and shadows are the 95% confidence intervals determined by bootstrapping 1000 repetitions. The y-axis shows the magnitude of the response proportional to the shock. The x-axis shows the 12-month time period over which the response was traced out.
Fig. 4
Fig. 4
Impulse response functions of AMR in K. pneumoniae between primary care (PC) hospital outpatient (HO) and hospital inpatient (HI) settings. Solid lines are the estimated impulse responses of AMR after a shock consisting of a 1% relative increase of AMR in each healthcare setting, and shadows are the 95% confidence intervals determined by bootstrapping 1000 repetitions. The y-axis shows the magnitude of the response proportional to the shock. The x-axis shows the 12-month time period over which the response was traced out.

References

    1. Bergman M., Nyberg S., Huovinen P., Paakkari P., Hakanen A. Finnish study group for antimicrobial resistance. Association between antimicrobial consumption and resistance in Escherichia coli. Antimicrob Agents Chemother. 2009;53(3):912–917. - PMC - PubMed
    1. Gallini A., Degris E., Desplas M., et al. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. J Antimicrob Chemother. 2010;65(12):2650–2657. - PubMed
    1. Sun L., Klein E., Laxminarayan R. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis. 2012;55(5):687–694. - PubMed
    1. Vernaz N., Huttner B., Muscionico D., et al. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother. 2011;66(4):928–935. - PubMed
    1. European Centre for Disease Prevention and Control . ECDC; Stockholm: 2023. Antimicrobial consumption in the EU/EEA (ESAC-Net) - annual epidemiologial report 2022. 2022.

LinkOut - more resources